Earthworm Peptide

The manufacturing process begins with a controlled mild thermal treatment step. This stage is designed to induce partial unfolding of the native protein tertiary and quaternary structures without causing excessive denaturation or degradation. By relaxing the higher-order protein conformation, internal peptide bonds and enzymatic cleavage sites become more accessible, thereby significantly improving subsequent enzymatic hydrolysis efficiency and reducing reaction variability.

Following thermal pretreatment, a multi-enzyme system composed of selected proteases with complementary cleavage specificities is introduced. This enzymatic system enables a staged and controlled hydrolysis process, gradually breaking down large protein chains into smaller peptide fragments. The hydrolysis conditions-including temperature, pH, enzyme concentration, and reaction time-are carefully controlled to ensure that the degree of hydrolysis remains within a target range, preventing both insufficient hydrolysis (which would retain high-molecular-weight proteins) and over-hydrolysis (which could destroy functional peptide structures).

Once the enzymatic reaction reaches the desired endpoint, enzyme inactivation is achieved through combined pH adjustment and thermal deactivation. This step is critical to stabilize the peptide composition and prevent further uncontrolled degradation. The hydrolysate is then subjected to solid–liquid separation to remove insoluble residues, including unreacted protein fragments and non-dissolved organic matter. The clarified peptide solution undergoes membrane fractionation purification, which represents a key step in molecular weight control. Through selective filtration and fractionation, peptide populations are separated according to molecular size distribution.

This process allows enrichment of low-molecular-weight peptide fractions while reducing the proportion of high-molecular-weight residues and non-functional macromolecules. As a result, the overall peptide profile becomes more uniform and consistent across production batches, significantly improving reproducibility. The purified peptide solution is then concentrated under controlled conditions using multi-effect evaporation technology, which minimizes thermal degradation while increasing solids content. Finally, the concentrated solution is converted into a stable powder form via spray drying. This drying technique ensures rapid moisture removal while preserving peptide integrity and maintaining good solubility characteristics.

The product is composed of a complex mixture of low-molecular-weight peptide fractions derived from controlled enzymatic hydrolysis. These peptide populations include multiple functionally relevant groups that have been reported in scientific literature to be associated with various biological pathways, although all activities remain at the research stage.

Among the identified peptide fractions are angiotensin-converting enzyme (ACE)-inhibitory peptides, which are associated in experimental models with the modulation of blood pressure-related enzymatic pathways. Additionally, antioxidant-related peptide sequences have been observed to participate in the regulation of oxidative stress markers, potentially contributing to free radical scavenging activity under in vitro conditions.

Earthworm peptide also contains peptide fractions that have been investigated for their potential role in immune modulation, particularly through interactions with macrophage activity and inflammatory cytokine expression, including TNF-α and IL-6. Furthermore, certain peptide components are linked to lipid metabolism regulation and intestinal microbiota balance in preclinical research models, suggesting multi-pathway biological relevance at the experimental level.

Lumbricusin is identified as a characteristic marker peptide within earthworm-derived peptide systems. It is widely used in academic research as a representative biomolecule for tracing and characterizing peptide profiles derived from earthworm protein hydrolysates. In this context, it serves primarily as a structural and analytical reference indicator rather than a defined active pharmaceutical ingredient.

In addition to peptide fractions, the system retains naturally associated components derived from the original biological matrix. These include Lysenin-related antimicrobial peptide fragments, free amino acids, naturally occurring alkaloids, and trace mineral elements. The coexistence of these components forms a complex bioactive matrix, which may contribute to potential synergistic interactions at the formulation level, although such interactions remain subject to further scientific investigation.

Supplementary technical note: Lysenin is a sphingomyelin-binding pore-forming protein originally derived from earthworm species. In controlled in vitro experimental systems, it has been shown to interact with lipid membrane structures and may increase membrane permeability of erythrocytes at certain concentration thresholds, resulting in hemolytic activity. Therefore, its presence requires careful consideration during formulation design, and its content should be appropriately evaluated and controlled depending on the intended application scenario.

All reported biological activities associated with this peptide system are derived exclusively from in vitro cell-based experiments and in vivo animal studies. These findings represent early-stage scientific research outcomes and should be interpreted strictly within a preclinical research context. No validated human clinical data are currently available to confirm physiological efficacy or therapeutic outcomes.

In circulatory system-related research models, certain low-molecular-weight peptide fractions have demonstrated potential involvement in fibrin degradation pathways. Experimental observations suggest possible effects on blood rheology parameters and microcirculation-related indicators, primarily through interactions with fibrinolytic system components. However, it is important to note that the fibrinolytic activity of enzymatically derived peptide fractions is significantly lower than that of native earthworm lumbrokinase enzymes, which are structurally distinct and functionally more active in fibrin degradation.

In immunological and inflammatory response studies, peptide components have been observed to modulate macrophage phagocytic activity and influence the expression levels of key pro-inflammatory cytokines, including tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6). These findings suggest potential involvement in immune response regulation pathways, particularly in maintaining inflammatory balance under experimental stress conditions.

In antioxidant and cellular protection research, the peptide system has demonstrated free radical scavenging capacity in chemical and cellular assays. These properties may contribute to reduced oxidative stress-induced cellular damage in vitro, supporting its frequent use as a research material in exploratory studies related to skin barrier protection, cellular stress response, and superficial tissue repair models.

Due to its low molecular weight peptide composition and excellent aqueous solubility, earthworm peptide has achieved relatively mature industrial application in selected formulation sectors, particularly in functional nutrition and personal care product development. In functional food and dietary supplement applications, the ingredient can be incorporated into solid beverage systems, meal replacement formulations, and sports nutrition products.

It serves as a highly bioavailable peptide-based nitrogen source designed to optimize dietary protein composition. In formulation systems, it is used to support improved protein digestion and absorption efficiency, particularly in protein-fortified nutritional products where enhanced bioavailability is a key formulation objective. In personal care and cosmetic applications, the peptide system exhibits amphiphilic molecular characteristics, enabling partial interfacial activity that may contribute to emulsification support and formulation stabilization in aqueous systems.

In combination with observed antioxidant and cellular protection trends from in vitro studies, the material is suitable for inclusion in soothing, moisturizing, and restorative skincare formulations such as serums, emulsions, and cream systems. In the field of biomaterials and advanced material science, current applications remain at the laboratory research stage. Investigations are primarily focused on improving hydrophilicity, structural flexibility, and dispersion stability in water-based polymer systems. At present, no large-scale industrial implementation or commercialized material systems have been established in this domain.